Requests that the FDA update the Indications and Usage section of the Full Prescribing Information for Premarin tablets to include pertinent information about the estrogen hormone, equilin. | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2025-P-7111

Requests that the FDA update the Indications and Usage section of the Full Prescribing Information for Premarin tablets to include pertinent information about the estrogen hormone, equilin.

Documents

Comments

Key Dates

Comment Period OpensDec 17, 2025

Documents

Type	Title	Posted	Comments	Status
Other	Interim Response	Jun 9, 2026	--

Keywords

CDER

Citizen Petition

Diamond Research Foundation

update the Indications and Usage

section of the Full Prescribing Information

for Premarin tablets to include pertinent

information about the estrogen hormone equilin

OPEN

Data from Regulations.gov